umifenovir has been researched along with oseltamivir in 18 studies
| Studies (umifenovir) | Trials (umifenovir) | Recent Studies (post-2010) (umifenovir) | Studies (oseltamivir) | Trials (oseltamivir) | Recent Studies (post-2010) (oseltamivir) |
|---|---|---|---|---|---|
| 234 | 23 | 172 | 3,368 | 186 | 2,014 |
| Protein | Taxonomy | umifenovir (IC50) | oseltamivir (IC50) |
|---|---|---|---|
| Neuraminidase | Influenza A virus (A/Turkey/651242/2006(H5N1)) | 0.1104 | |
| Neuraminidase | Influenza A virus (A/Wilson-Smith/1933(H1N1)) | 0.2616 | |
| Neuraminidase | Influenza A virus (A/duck/Laos/25/2006(H5N1)) | 2.0317 | |
| Neuraminidase | Influenza A virus (A/Puerto Rico/8/1934(H1N1)) | 1.1344 | |
| Neuraminidase | Influenza A virus (A/USSR/90/1977(H1N1)) | 0.002 | |
| Neuraminidase | Influenza B virus (B/Lee/1940) | 0.005 | |
| Acyl-CoA desaturase 1 | Mus musculus (house mouse) | 0.008 | |
| Neuraminidase | Influenza A virus (A/chicken/Yogjakarta/BBVet-IX/2004(H5N1)) | 0.0043 | |
| Neuraminidase | Influenza A virus (A/Thailand/1(KAN-1)/2004(H5N1)) | 0.0003 | |
| Neuraminidase | Influenza A virus (A/Singapore/1/1957(H2N2)) | 0.003 | |
| Neuraminidase | Influenza A virus (A/Aichi/2/1968(H3N2)) | 0.0016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 10 (55.56) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Lin, W; Liu, D; Proksch, P; Si, L; Zhang, L; Zhou, D | 1 |
| Lin, W; Liu, D; Niu, S; Shao, Z; Si, L; Wang, S; Zhang, L; Zhang, Z; Zhou, A; Zhou, D | 1 |
| Duan, Z; Gu, Q; Li, D; Li, J; Liu, Y; Wang, W; Wu, G; Yang, S; Yu, G; Yu, R; Yu, Y; Zhu, T | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Bondarev, VP; Borisevich, SV; Loginova, SIa; Maksimov, VA; Nebol'sin, VE | 1 |
| Bondarev, VP; Borisevich, SV; Loginova, SIa; Maksimov, VA; Nebol'sin, VE; Shkliaeva, OM | 1 |
| Li, JF; Shen, JS; Xiong, RS; Zhang, Q; Zhao, QJ | 1 |
| Deriabin, PG; Fediakina, IT; Gudova, NV; Kondrat'eva, TV; L'vov, DK; Leneva, IA; Shchelkanov, MIu | 1 |
| Arastoo, M; Khorshid, HR | 1 |
| Burtseva, EI; Fedyakina, IT; Kirillova, ES; Leneva, IA; Maleev, VV; Osipova, E; Selkova, EP; Yatsyshina, SB | 1 |
| Duan, Y; Zhou, C; Zhu, HL | 1 |
| Cutrell, JB; Jodlowski, TZ; Monogue, ML; Sanders, JM | 1 |
| Cai, W; Cao, Y; Chen, X; Hu, F; Li, F; Li, L; Li, Y; Lin, W; Ou, X; Tang, X; Wen, C; Xie, Z | 1 |
| Chen, C; Chen, Y; Hu, F; Liu, J; Song, J; Song, Y; Tang, X; Ye, M; Yin, G; Zhang, Y | 1 |
| Gao, Q; Liu, D; Ma, D; Song, C; Tan, J; Xu, C; Yuan, Y | 1 |
| Wen, S; Xu, X; Yadav, AK; Yu, L | 1 |
| Boonma, T; Nunthaboot, N; Nutho, B; Rungrotmongkol, T; Soikudrua, N | 1 |
| Bai, X; Chen, G; Fan, X; Li, Y; Tian, Y; Wang, K; Wang, W; Xi, S; Zhao, Y | 1 |
3 review(s) available for umifenovir and oseltamivir
| Article | Year |
|---|---|
[Research progress of anti-influenza virus agents].
Topics: Acids, Carbocyclic; Amantadine; Antiviral Agents; Cyclopentanes; Guanidines; Humans; Indoles; Influenza, Human; Neuraminidase; Orthomyxoviridae; Oseltamivir; Pyrrolidines; Rimantadine; Structure-Activity Relationship; Viral Matrix Proteins; Zanamivir | 2010 |
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Azithromycin; Betacoronavirus; Chloroquine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Hydroxychloroquine; Immunoglobulins; Immunologic Factors; Indoles; Lopinavir; Oseltamivir; Pandemics; Pneumonia, Viral; Pyrazines; Ribavirin; Ritonavir; SARS-CoV-2; Withholding Treatment | 2020 |
Antiviral treatment in COVID-19: which is the most promising?-a narrative review.
Topics: Adenosine Monophosphate; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Azetidines; Chloroquine; COVID-19; COVID-19 Serotherapy; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Indoles; Interferons; Ivermectin; Lopinavir; Nitro Compounds; Oseltamivir; Purines; Pyrazines; Pyrazoles; Ribavirin; Ritonavir; Sulfonamides; Thiazoles | 2021 |
1 trial(s) available for umifenovir and oseltamivir
| Article | Year |
|---|---|
Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases.
Topics: Capsules; Fever; Humans; Influenza, Human; Nausea; Oseltamivir; Phosphates; Tablets | 2023 |
14 other study(ies) available for umifenovir and oseltamivir
| Article | Year |
|---|---|
Neoechinulin B and its analogues as potential entry inhibitors of influenza viruses, targeting viral hemagglutinin.
Topics: Alkaloids; Animals; Antiviral Agents; Cell Line, Tumor; Cell Survival; Cytopathogenic Effect, Viral; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Viral; Eurotium; HEK293 Cells; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Madin Darby Canine Kidney Cells; Molecular Structure; Piperazines; Structure-Activity Relationship; Viral Plaque Assay | 2015 |
Spiromastilactones: A new class of influenza virus inhibitors from deep-sea fungus.
Topics: Animals; Antiviral Agents; Aquatic Organisms; Benzofurans; Dogs; Dose-Response Relationship, Drug; Influenza A virus; Lactones; Madin Darby Canine Kidney Cells; Microbial Sensitivity Tests; Onygenales; Structure-Activity Relationship | 2016 |
Chemoreactive-Inspired Discovery of Influenza A Virus Dual Inhibitor to Block Hemagglutinin-Mediated Adsorption and Membrane Fusion.
Topics: Acetophenones; Adsorption; Animals; Antiviral Agents; Dogs; Drug Discovery; Drug Resistance, Viral; Female; Hemagglutinin Glycoproteins, Influenza Virus; Influenza A virus; Madin Darby Canine Kidney Cells; Membrane Fusion; Mice; Tissue Distribution; Virus Internalization; Virus Replication | 2020 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Therapeutic efficacy of Ingavirin, a new domestic formulation against influenza A virus (H3N2)].
Topics: Amides; Animals; Antiviral Agents; Caproates; Dicarboxylic Acids; Imidazoles; Indoles; Influenza A Virus, H3N2 Subtype; Lung; Mice; Orthomyxoviridae Infections; Oseltamivir; Rimantadine; Virus Replication | 2008 |
[Prophylactic and therapeutic efficacies of Ingavirin, a novel Russian chemotherapeutic, with respect to influenza pathogen A (H5N1)].
Topics: Amides; Animals; Antiviral Agents; Caproates; Dicarboxylic Acids; Humans; Imidazoles; Indoles; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mice; Mice, Inbred Strains; Orthomyxoviridae Infections; Oseltamivir | 2010 |
[Susceptibility of pandemic influenza virus A 2009 H1N1 and highly pathogenic avian influenza virus A H5N1 to antiinfluenza agents in cell culture].
Topics: Animals; Antiviral Agents; Birds; Cell Line; Drug Resistance, Viral; Humans; Indoles; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Oseltamivir; Ribavirin; Rimantadine; Virus Replication | 2011 |
Do we need a replacement medication for influenza with good efficacy?
Topics: Antiviral Agents; Drug Combinations; Drug Synergism; Humans; Indoles; Influenza A Virus, H1N1 Subtype; Influenza, Human; Oseltamivir; Plant Extracts; Treatment Outcome; Zanamivir | 2014 |
Virus susceptibility and clinical effectiveness of anti-influenza drugs during the 2010-2011 influenza season in Russia.
Topics: Adult; Animals; Antiviral Agents; Cell Line; Dogs; Enzyme Inhibitors; Female; Humans; Indoles; Influenza A Virus, H1N1 Subtype; Influenza, Human; Male; Mice; Mice, Inbred BALB C; Middle Aged; Neuraminidase; Oseltamivir; Retrospective Studies; Russia; Treatment Outcome; Young Adult | 2016 |
Advance of promising targets and agents against COVID-19 in China.
Topics: Adenine; Adenosine Monophosphate; Alanine; Amides; Antimalarials; Antiviral Agents; Betacoronavirus; China; Chloroquine; Clinical Trials as Topic; Cobicistat; Coronavirus 3C Proteases; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cysteine Endopeptidases; Dibenzothiepins; Drug Combinations; Drug Discovery; Drug Therapy, Combination; Emtricitabine; Humans; Hydroxychloroquine; Indoles; Lopinavir; Medicine, Chinese Traditional; Morpholines; Oseltamivir; Oxazines; Pandemics; Pneumonia, Viral; Pyrazines; Pyridines; Pyridones; Ritonavir; RNA-Dependent RNA Polymerase; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Tenofovir; Thiepins; Triazines; Viral Nonstructural Proteins | 2020 |
Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with coronavirus disease 2019.
Topics: Adult; Anal Canal; Antiviral Agents; C-Reactive Protein; Chloroquine; COVID-19; COVID-19 Testing; Female; Hospitalization; Humans; Indoles; Intensive Care Units; Lymphopenia; Male; Middle Aged; Oseltamivir; Pharynx; Retrospective Studies; RNA, Viral; SARS-CoV-2; Severity of Illness Index; Viral Load | 2021 |
Corticosteroid, oseltamivir and delayed admission are independent risk factors for prolonged viral shedding in patients with Coronavirus Disease 2019.
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Betacoronavirus; China; Coronavirus Infections; COVID-19; Female; Hospitalization; Humans; Immunoglobulins; Indoles; Interferons; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Factors; SARS-CoV-2; Time Factors; Virus Shedding | 2020 |
A retrospective comparison of drugs against COVID-19.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies, Viral; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Female; Humans; Hydroxychloroquine; Immunoglobulin G; Immunoglobulin M; Indoles; Length of Stay; Lopinavir; Male; Middle Aged; Oseltamivir; Retrospective Studies; Ritonavir; SARS-CoV-2; Young Adult | 2021 |
Insights into binding molecular mechanism of hemagglutinin H3N2 of influenza virus complexed with arbidol and its derivative: A molecular dynamics simulation perspective.
Topics: Antiviral Agents; Hemagglutinins; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Molecular Dynamics Simulation; Oseltamivir | 2022 |